Friday, 10 June 2016
Roche launches home testing device for anticoagulant patients in Europe
The market for home healthcare devices is growing at a steady clip. The Swiss diagnostics giant is launching its PT/INR home self-testing device in Europe, building out its offerings while potentially improving care for patients on anticoagulant therapy.
The Basel-based company's CoaguChek INRange system helps patients and doctors monitor coagulation and response to Vitamin K Antagonist (VKA) therapy. CoaguChek INRange, which includes Bluetooth technology, could offer an advantage over the current standard of care.
Patients on VKA therapy usually have to visit the hospital or a doctor's office for PT/INR testing done with a needle, and then wait up to 2-3 days for lab results. Roche's system uses a fingerstick and 60-second test to generate results, the company said in a statement, which could cut down on lab visits.